Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Anika Therapeutics, Inc.

AgelessRx provides anti-aging treatments supported by longevity science. The organization offers various therapies to assist individuals in managing health concerns related to aging.

AgelessRx

ALPHAEON is a healthcare company that develops and provides aesthetic products and medical devices for healthcare professionals and patients

ALPHAEON

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

West Pharmaceutical Services, Inc.

Anika Therapeutics is a global joint preservation company focused on early intervention orthopedic care, offering solutions for joint pain and arthritis.

Metric
Company Name	Anika Therapeutics, Inc.	AgelessRx	ALPHAEON	West Pharmaceutical Services, Inc.
Symbol	ANIK			WST
MSH ID	COM:ANIKA	COM:AGELESSRX	COM:ALPHAEON	COM:WESTPHARMA
Market	STOCKS	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Healthcare
Industry	Medical - Devices	Medical Services	Medical Devices and Aesthetics	Medical - Instruments & Supplies
Country	US	US	US	US
Stage
Employee Count	357			10.60K
Website	anikatherapeutics.com	agelessrx.com	alphaeon.com	westpharma.com
LinkedIn
Founders

Metric
Market Cap	389.26M	23.41B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	166.66M	2.95B
Revenue (LTM)
Revenue (NTM)
Gross Profit	103.09M	1.13B
EBITDA	-11.21M	875.70M
Operating Income	-25.45M	676M
Net Income	-82.67M	593.40M
EPS	-5.64	7.98
Diluted EPS	-5.64	7.88
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.62	0.38
Operating Profit Margin	-0.08	0.23
EBITDA Margin	-0.07	0.30
Net Profit Margin	-0.44	0.20
Return on Equity	-0.32	0.21
Return on Assets	-0.28	0.16
Return on Capital Employed	-0.06	0.22

COM:ANIKA

Anika Therapeutics

Last Close

17.43

22/11 21:00

Market Cap

389.26M

Beta: -

Volume Today

61.03K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-14.02	52.81
P/B Ratio	1.27	10.30
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.52	9.76
EV Multiple	-28.38	34.90

Metric
Days Sales Outstanding	77.51	64.74
Days Payables Outstanding	48.25	44.24
Days Inventory Outstanding	295.29	87.15
Operating Cycle	369.15	150.56
Cash Conversion Cycle	311.81	104.66
Asset Turnover	0.64	0.82

Metric
Operating Cash Flow	-1.79M	776.50M
Free Cash Flow	-7.21M	414.50M
Cash Flow to Debt	0.32	3.31
Operating Cash Flow/Sales	0.05	0.26
Free Cash Flow Yield	-0.03	0.01

Metric
Cash & Equivalents	72.87M	853.90M
Accounts Receivable	-1.30M	4M
Inventory	46.39M	434.70M
Goodwill	7.57M	108.50M
Debt to Capitalization	0.12	0.10
Debt to Assets	0.08	0.08
Current Ratio	5.59	3.70
Quick Ratio	3.96	2.03

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.09	0.01
R&D to Revenue	0.20	0.02
SG&A to Revenue